C6461010 An international, open-label, phase 2 study to investigate the safety and efficacy of PF-08634404 monotherapy or in combination in adult participants with early-stage resectable or locally advance unresectable non-small cell lung cancer.



Mary Beth Wilwerding, RN Admin@NEcancertrials.com



Available at Cancer Partners of Nebraska, Lincoln, NE location

Interested in More Information?

Please fill out the form below. Someone will get back to you as soon as possible.

"*" indicates required fields

Name*

Email*

Phone*

Message*